Neurelis logo

Neurelis Funding & Investors

Neurelis Inc., is a pharmaceutical company. The Company develops and commercializes product candidates for the treatment of central nervous system disorders, acute epilepsy, and anxiety episodes.

neurelis.com

Total Amount Raised: $156,098,000

Neurelis Funding Rounds

  • Series D

    $114,000,000

    Series D Investors

    HBM Healthcare Investments
    Cormorant Asset Management
    Decheng Capital
    LYZZ Capital
    Philos & Partners
  • Series B

    $42,098,000

    Series B Investors

    HBM Healthcare Investments
    LYZZ Capital
Funding info provided by Diffbot.